Leprosy Treatment Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024
Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale. Some of them subsidized the treatment to eradicate the presence of the disease from their countries. Therefore government regulation as well as adoption remains the most important driver of the leprosy treatment market.
Request Report Sample for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/128
Asia Pacific, especially India remains one of the most affected countries. As per the World Health Organization reports, about 59% of the new cases reported were from India. According to stats released by the Leprosy Mission Trust, around 127,000 new occurrences of leprosy were reported from India alone during 2013–2014. Out of these, about 46% were women and children. In India, the prevalence rate according to The Leprosy Mission Trust in the year 2014 was about 0.68 per 10,000 population. The National Leprosy Eradication Programme (NLEP) is one such initiative by the Indian government that aims to eradicate the disease from the country by 2018. Therefore, leprosy treatment market in this region is projected to grow at a considerable rate in the near future.
Key Players in Leprosy Treatment Market
Companies operating in the leprosy treatment market include Glaxo Smithcline Pharmaceuticals Ltd., Systopic Laboratories Pvt. Ltd., Acme Pharmaceuticals, Cadila Pharmaceuticals, Macleods Pharmaceuticals, IDPL, Astra Zeneca Pharma India Ltd., Lark Laboratories (UIndia) Ltd., Genetic Pharma, and Novartis International AG.
Leprosy or Hansen's disease (HD) is a chronic infection caused by Mycobacterium lepromatosis or Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease. Symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. Nerve damage is the primary cause for numbness of muscles. Leprosy is a communicable disease that can be propagated through contact with cough or phlegm of the affected person. Other risk factors of leprosy include malnutrition and weak immune system. Leprosy is especially prevalent in low-income countries.
Request Discount: https://www.coherentmarketinsights.com/insight/request-discount/128
Leprosy Treatment Market Outlook
According to the statistics received by the World Health Organization (WHO), from various regions (138 countries), the number of registered cases of leprosy was 176,176 in 2015, that is 0.18 cases per 10 000 people. The number of new cases shows the degree of sustained transmission of the disease. Global statistics illustrate that 203,600 (96%) of fresh leprosy cases were from 22 key countries. Prevalence of high occurrences is a reminder that some areas around the world show high incidences of the disease and experience very high rate of transmission. According to WHO, around 16 million cases of leprosy have been treated in the last two decades. Governing bodies and governments alike are trying to eradicate the presence of the disease on a global scale. Owing to these factors, the leprosy treatment market is expected to grow at substantial rate over the forecast period (2016–2024).
Leprosy Treatment Market Taxonomy
On the basis of type of leprosy, the global leprosy treatment market is classified into:
Early and indeterminate leprosy treatment
Borderline tuberculoid leprosy treatment
Tuberculoid leprosy treatment
Borderline leprosy treatment
Histoid leprosy treatment
Lepromatous leprosy treatment
Borderline lepromatous leprosy treatment
Diffuse leprosy of Lucio and Latapí
On the basis of treatment, the global leprosy treatment market is classified into:
On the basis of type of end user, the global leprosy treatment market is classified into:
As per National Leprosy Eradication Programme (NLEP), leprosy has been broadly categorized into two segments namely, paucibacillary leprosy (one to five skin lesions, maximum one nerve with skin liaisons) and multibacillary leprosy (over six skin liaisons, more than one nerve with skin liaisons). Early detection of the disease is an important factor for effective treatment, though various drugs are available for late stage leprosy patients. The most common treatment is multidrug therapy. The drugs recommended by WHO multidrug therapy are rifampicin, dapsone, and clofazimine. Among these, rifampicin is most preferred for treatment of leprosy. Treatment with everyday dapsone and monthly treatment with rifampcin for six months is followed for paucibacillary (PB or tuberculoid) cases. For multibacillary (MB or lepromatous) cases, the treatment is a prolongrd one. It includes daily dapsone and clofazimine. Additionally, monthly rifampicin is recommended for 12 months. Side effects, resistance, and relapse rate are low in multidrug therapy. Some of the other drugs available for leprosy treatment are rifadine and rimactane. The leprosy treatment market is projected to witness a steep inlince in the number of novel drugs and availability of the same, due to increasing initiatives across the globe to eradicate this menace.
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/leprosy-treatment-market-128
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leprosy Treatment Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024 here
News-ID: 466703 • Views: 201
More Releases from Leprosy Treatment Market
Leprosy Treatment Market - Global industry analysis and forecast 2016-2024
Leprosy Treatment Market Future Outlook: Asia Pacific to be Key Growth Market Leprosy has been endemic to mankind since many decades. This needed interference of various governments around the world as well as the World Health Organization. Governments play an important role in the leprosy treatment market. Ever since the introduction of multidrug therapy by WHO in 1982, governments around the world have adopted this treatment procedure on a large scale.
More Releases for India
Medical Tour India | Affordable Treatment In India
We at MedCredible look after the well being of the patients seeking treatment in India. Our support staff support is well trained in handling various situations arising due to cross border differences. All the patients can avail of high-quality treatment at an extremely affordable cost in a compassionate environment combined with ethical practices. With options of over 100 + Hospitals and Institutions, we at Medcredible ensure that we connect the
IVF India, Test Tube baby India
The aim of setting up KJIVF is to help infertile couples in achieving conception through modern diagnostic and treatment methods. KJIVF Centre has given the best results by blessing infertile couples of advanced age with children, these couples could never dream of becoming parents. Thousands of babies are conceived through in-vitro fertilization (IVF) each year; In-Vitro Fertilization (IVF) means fertilization outside the body. A baby developed from an egg that
Beach Holiday India- Best Beaches in India
The natural beauty, exotic locations and rich heritage has helped India to stand as the most visited and most popular tourist spot in the world. The status of “Incredible India”, is defined by an incredible range of nature’s blessings on the Indian subcontinent and this incredibility is doubled by one of the most fabulous tourism option available in the country that are the brilliant and majestic beaches in India.
ISO 27001 India, 27001 training India ISO
Coral eSecure is information Risk Management advisory with specific focus on Information Security (ISO 27001, ISO 17799, PCI, COBIT, HIPAA, GLBA, and DPA), Business Continuity (BS25999) and ITIL/ IT Service Management (ISO 20000). Coral is the FIRST Indian consulting organization which provides an Integrated Management System Consulting, Consisting of ISO 27001, ISO 20000 and BS25999 – ALL THREE IN ONE! Coral provides Consulting, Assurance audit and Training to address these
Interior Designers India, Designers and Architects India
Today, we have recognized ourselves as a booming beauty interior designing firm, offering services that include interior designing. We are a winning firm, which is based on the strong foundation of innovative and original ideas for interior, architectural and landscaping designing services. Synergy Corporate Interior Design Association has more corporate members. Who provide Products and services. We support Interior Designers India, Designers and Architects India. We are committed to the
Domain Registration India, Web Hosting India, Payment Gateway India
Indiainternet.in is a Quality Web Hosting Company India, provide all web related support and Web hosting services like linux web hosting, windows web hosting, web hosting packages, domain registration in india, Corporate email solution, business email hosting, payment gateway integration, SSL with supports like free php, cgi, asp, free msaccess, free cdonts, free webmail, web based control panel, unlimited ftp access, unlimited data transfer. During the domain registration process, you will